title: Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.
abstract: Right ventricular failure (RVF) is the leading cause of death in pulmonary arterial hypertension (PAH). Some patients with pulmonary hypertension are adaptive remodelers and develop RV hypertrophy (RVH) but retain RV function; others are maladaptive remodelers and rapidly develop RVF. The cause of RVF is unclear and understudied and most PAH therapies focus on regressing pulmonary vascular disease. Studies in animal models and human RVH suggest that there is reduced glucose oxidation and increased glycolysis in both adaptive and maladaptive RVH. The metabolic shift from oxidative mitochondrial metabolism to the less energy efficient glycolytic metabolism may reflect myocardial ischemia. We hypothesize that in maladaptive RVH a vicious cycle of RV ischemia and transcription factor activation causes a shift from oxidative to glycolytic metabolism thereby ultimately promoting RVF. Interrupting this cycle, by reducing ischemia or enhancing glucose oxidation, might be therapeutic. Dichloroacetate, a pyruvate dehydrogenase kinase inhibitor, has beneficial effects on RV function and metabolism in experimental RVH, notably improving glucose oxidation and enhancing RV function. This suggests the mitochondrial dysfunction in RVH may be amenable to therapy. In this mini review, we describe the role of impaired mitochondrial metabolism in RVH, using rats with adaptive (pulmonary artery banding) or maladaptive (monocrotaline-induced pulmonary hypertension) RVH as models of human disease. We will discuss the possible mechanisms, relevant transcriptional factors, and the potential of mitochondrial metabolic therapeutics in RVH and RVF.
authors.affiliation: Section of Cardiology, Department of Medicine, University of Chicago, Chicago, IL, USA.
authors.forename: Lin
authors.initials: L
authors.lastname: Piao
authors.forename: Glenn
authors.initials: G
authors.lastname: Marsboom
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Archer
mesh_terms: D000222:Adaptation, Physiological / Q000502:physiology*; D000818:Animals; D005227:Fatty Acids / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006333:Heart Failure / Q000503:physiopathology*; D006801:Humans; D017380:Hypertrophy, Right Ventricular / Q000503:physiopathology*; D008928:Mitochondria / Q000502:physiology*; D010084:Oxidation-Reduction; D010100:Oxygen / Q000378:metabolism
chemical_list: D005227:Fatty Acids; D005947:Glucose; D010100:Oxygen
references.citation: Heart Vessels. 2009 Jul;24(4):277-82
references.pmid: 19626400
references.citation: Am J Physiol. 1997 Jun;272(6 Pt 2):H2833-42
references.pmid: 9227563
references.citation: Nat Rev Cancer. 2008 Jan;8(1):51-6
references.pmid: 18046334
references.citation: Am J Physiol. 1999 Nov;277(5):H1725-31
references.pmid: 10564125
references.citation: Acta Pharmacol Sin. 2004 Feb;25(2):226-30
references.pmid: 14769214
references.citation: Circulation. 2002 Jan 15;105(2):244-50
references.pmid: 11790708
references.citation: Expert Opin Investig Drugs. 2002 May;11(5):615-29
references.pmid: 11996644
references.citation: Circ Res. 2000 Mar 17;86(5):580-8
references.pmid: 10720420
references.citation: Cardiovasc Res. 1991 Sep;25(9):731-9
references.pmid: 1839241
references.citation: Eur Heart J. 2007 May;28(10):1250-7
references.pmid: 17242010
references.citation: Ann Nucl Med. 1997 Aug;11(3):207-12
references.pmid: 9310169
references.citation: Kardiol Pol. 2008 Oct;66(10):1033-9; discussion 1040-1
references.pmid: 19006024
references.citation: Cardiovasc Res. 1997 Feb;33(2):243-57
references.pmid: 9074687
references.citation: Am J Physiol. 1970 Jan;218(1):153-9
references.pmid: 4243400
references.citation: Cardiol J. 2008;15(4):344-50
references.pmid: 18698543
references.citation: Cardiovasc Res. 2003 Jul 1;59(1):143-51
references.pmid: 12829185
references.citation: J Am Coll Cardiol. 2005 Jun 7;45(11):1849-55
references.pmid: 15936618
references.citation: J Mol Med (Berl). 2010 Jan;88(1):47-60
references.pmid: 19949938
references.citation: J Exp Biol. 2004 Aug;207(Pt 18):3189-200
references.pmid: 15299040
references.citation: EMBO J. 2006 Aug 23;25(16):3869-79
references.pmid: 16902412
references.citation: J Electrocardiol. 2005 Oct;38(4 Suppl):154-8
references.pmid: 16226092
references.citation: Am J Physiol. 1998 Dec;275(6):H1948-56
references.pmid: 9843792
references.citation: Physiol Genomics. 2005 May 11;21(3):314-23
references.pmid: 15728335
references.citation: Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1107-14
references.pmid: 17496214
references.citation: Europace. 2007 Sep;9 Suppl 4:iv4-15
references.pmid: 17766323
references.citation: Nat Clin Pract Cardiovasc Med. 2006 Sep;3(9):490-8
references.pmid: 16932766
references.citation: Circulation. 2009 Nov 17;120(20):1951-60
references.pmid: 19884466
references.citation: J Cardiovasc Electrophysiol. 2006 May;17 Suppl 1:S169-S177
references.pmid: 16686675
references.citation: J Cardiovasc Pharmacol. 1996 Sep;28(3):353-62
references.pmid: 8877580
references.citation: J Thorac Cardiovasc Surg. 2008 Jul;136(1):168-78, 178.e1-3
references.pmid: 18603070
references.citation: Am J Physiol. 1998 Jul;275(1):H169-75
references.pmid: 9688910
references.citation: Eur Respir J. 2010 Jun;35(6):1286-93
references.pmid: 19897557
references.citation: Circulation. 2008 Sep 16;118(12):1250-8
references.pmid: 18765391
references.citation: Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H1185-92
references.pmid: 14630626
references.citation: Cardiovasc Diabetol. 2003 Nov 28;2:16
references.pmid: 14641923
references.citation: J Am Coll Cardiol. 2001 Oct;38(4):1137-42
references.pmid: 11583894
references.citation: Eur Heart J. 2008 Jan;29(1):120-7
references.pmid: 18065750
references.citation: J Mol Cell Cardiol. 1996 Feb;28(2):341-50
references.pmid: 8729066
references.citation: Ann Nucl Med. 2007 Dec;21(10):569-76
references.pmid: 18092133
references.citation: J Clin Invest. 2010 Jan;120(1):142-56
references.pmid: 20038799
references.citation: Annu Rev Physiol. 1974;36:413-59
references.pmid: 19400669
references.citation: J Cell Biochem. 1994 Jan;54(1):78-84
references.pmid: 8126088
references.citation: J Pharmacol Sci. 2009 Sep;111(1):33-43
references.pmid: 19763046
references.citation: J Heart Lung Transplant. 1997 Jul;16(7):774-85
references.pmid: 9257260
references.citation: Circulation. 1981 Jan;63(1):87-95
references.pmid: 7438411
references.citation: J Mol Cell Cardiol. 1997 Jul;29(7):1903-13
references.pmid: 9236144
references.citation: Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H1038-47
references.pmid: 20061549
references.citation: Heart Fail Rev. 2007 Dec;12(3-4):331-43
references.pmid: 17516164
references.citation: Curr Clin Pharmacol. 2007 Sep;2(3):190-6
references.pmid: 18690865
references.citation: Circulation. 1996 Jan 1;93(1):135-42
references.pmid: 8616920
references.citation: Cardiovasc Res. 2007 Sep 1;75(4):770-81
references.pmid: 17582388
references.citation: J Pharmacol Exp Ther. 2007 Apr;321(1):213-20
references.pmid: 17202401
references.citation: Biochem J. 2000 Dec 15;352 Pt 3:731-8
references.pmid: 11104680